Skip to main navigation
Skip to search
Skip to main content
Research Explorer The University of Manchester Home
Home
Profiles
Research units
Research output
Projects
Impacts
Activities
Press/Media
Prizes
Equipment
Datasets
Student theses
Search by expertise, name or affiliation
Optimisation of CHO for Biotherapeutic Manufacture
Dickson, Alan
(PI)
Barran, Perdita
(CoI)
Pitt, Andrew
(CoI)
Rattray, Magnus
(CoI)
Schwartz, Jean-Marc
(CoI)
CE - Academic & Research
Analytical, Measurements and Physical Chemistry
Division of Informatics, Imaging & Data Sciences (L5)
Division of Evolution, Infection and Genomics
Overview
Fingerprint
Research output
(1)
Project Details
Status
Active
Effective start/end date
1/10/21
→
30/09/26
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Mass Spectrometry
Biochemistry, Genetics and Molecular Biology
100%
Solution and Solubility
Biochemistry, Genetics and Molecular Biology
100%
Trastuzumab
Biochemistry, Genetics and Molecular Biology
100%
Immunology
Immunology and Microbiology
100%
Light Chain
Biochemistry, Genetics and Molecular Biology
66%
Copurification
Biochemistry, Genetics and Molecular Biology
66%
Volume
Biochemistry, Genetics and Molecular Biology
66%
Immunoglobulin G1 Antibody
Immunology and Microbiology
66%
Research output
Research output per year
2024
2024
2024
1
Article
Research output per year
Research output per year
Hybrid mass spectrometry applied across the production of antibody biotherapeutics.
Christofi, E., OHanlon, M.,
Curtis, R.
, Barman, A., Keen, J., Nagy, T. &
Barran, P.
,
1 Oct 2024
, (Accepted/In press)
In:
Journal of the American Society for Mass Spectrometry.
Research output
:
Contribution to journal
›
Article
›
peer-review
Solution and Solubility
100%
Mass Spectrometry
100%
Trastuzumab
100%
Immunology
100%
Copurification
66%